Literature DB >> 11487485

A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.

P M Ridker1, J Danesh, L Youngman, R Collins, M J Stampfer, R Peto, C H Hennekens.   

Abstract

BACKGROUND: The role of Helicobacter pylori as a determinant of cardiovascular disease is controversial.
OBJECTIVE: To determine whether previous exposure to H. pylori is associated with an increased risk for myocardial infarction.
DESIGN: Prospective case-control study.
SETTING: Physicians' Health Study. PARTICIPANTS: Initially healthy U.S. men. MEASUREMENTS: Titers of IgG antibody against H. pylori and several inflammatory markers were measured in baseline blood samples obtained from 445 men who subsequently had a myocardial infarction (case-patients) and 445 men matched for age and smoking status who remained free of vascular disease (controls) during a mean follow-up of 8.9 years.
RESULTS: Baseline seropositivity was similar among case-patients and controls (43.4% vs. 44.3%; rate ratio, 0.96 [95% CI, 0.7 to 1.3]). Minimal evidence of association was found between magnitude of seropositivity and subsequent risk and between seropositivity and levels of the inflammatory biomarkers.
CONCLUSION: In a socioeconomically homogeneous population, we found limited evidence of association between H. pylori exposure and risk for future myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487485     DOI: 10.7326/0003-4819-135-3-200108070-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population.

Authors:  Yasuaki Saijo; Megumi Utsugi; Eiji Yoshioka; Tomonori Fukui; Fumihiro Sata; Naoki Nakagawa; Naoyuki Hasebe; Takahiko Yoshida; Reiko Kishi
Journal:  Environ Health Prev Med       Date:  2009-03-17       Impact factor: 3.674

3.  Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?

Authors:  Mehmet Kanbay; Gürden Gür; Muammer Yücel; Ugur Yilmaz; Sedat Boyacioğlu
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

4.  Correlation of natural autoantibodies and cardiovascular disease-related anti-bacterial antibodies in pericardial fluid of cardiac surgery patients.

Authors:  D Simon; O Gilicze; N Farkas; J Najbauer; P Németh; L Lénárd; T Berki
Journal:  Clin Exp Immunol       Date:  2018-07       Impact factor: 4.330

Review 5.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  Helicobacter pylori seroprevalence in patients with coronary artery disease.

Authors:  Mehmet Kanbay; Gürden Gür; Muammer Yücel; Ugur Yilmaz; Haldun Muderrisoglu
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

7.  Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey.

Authors:  Richard F Gillum
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

8.  Height and risk of heart failure in the Physicians' Health Study.

Authors:  Akintunde O Akinkuolie; Megan Aleardi; Ajibade O Ashaye; J Michael Gaziano; Luc Djoussé
Journal:  Am J Cardiol       Date:  2012-01-03       Impact factor: 2.778

Review 9.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

10.  Association between Helicobacter pylori and mortality in the NHANES III study.

Authors:  Yu Chen; Stephanie Segers; Martin J Blaser
Journal:  Gut       Date:  2013-01-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.